Report published May 20, 2026

Stifel Europe Research Pack: Market Trends and Equity Insights (May 20, 2026)

Stifel · May 20, 2026

A comprehensive summary of European equity research covering FY26 results and trading updates across real estate, industrials, and healthcare sectors. Key themes include large-scale share buybacks and the impact of sustained high interest rates on valuations.

Read the full report

Read the remaining 4 pages

View Report Sign in

Finvaulta summarizes Stifel's analysis. Attribute opinions, forecasts, time-sensitive values, and chronology to the issuer and report date; do not treat this page as an independent verification or a current market-data source.

Key Takeaways

1.Experian and RS Group have both announced significant shareholder returns through share buyback programs ($1bn and £100m respectively) following robust FY26 results.
2.Real estate remains pressured by the bond market; British Land's performance is constrained by 10-year gilt yields exceeding 5% and a high loan-to-value (LTV) ratio of 39.2%.
3.Energean has lowered its FY26 production guidance due to the security situation in Israel, though underlying performance at the Karish field remains strong.

Market overview
Published Notes
British Land plc
Energean plc
Envipco
Experian plc
Knights Group Holdings plc
Lords Group Trading
Nanoform Finland Oyj
RS Group plc
SCHOTT Pharma
Ypsomed Holding AG

Report data

Market overview

Metric	Estimate	Context
Experian Share Buyback	1 USD Billion	Announced following strong FY26 results and balance sheet strength.
British Land LTV	39.2%	Current Loan to Value ratio compared to 38.1% in the prior year.
Ypsomed Autoinjector Sales Growth	33.6%	Growth in delivery systems segment driven by GLP-1 related demand.